1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Ponatinib Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Ponatinib by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Ponatinib by Country/Region, 2018, 2022 & 2029 2.2 Ponatinib Segment by Type 2.2.1 45mg 2.2.2 15mg 2.3 Ponatinib Sales by Type 2.3.1 Global Ponatinib Sales Market Share by Type (2018-2023) 2.3.2 Global Ponatinib Revenue and Market Share by Type (2018-2023) 2.3.3 Global Ponatinib Sale Price by Type (2018-2023) 2.4 Ponatinib Segment by Application 2.4.1 CML 2.4.2 ALL 2.5 Ponatinib Sales by Application 2.5.1 Global Ponatinib Sale Market Share by Application (2018-2023) 2.5.2 Global Ponatinib Revenue and Market Share by Application (2018-2023) 2.5.3 Global Ponatinib Sale Price by Application (2018-2023) 3 Global Ponatinib by Company 3.1 Global Ponatinib Breakdown Data by Company 3.1.1 Global Ponatinib Annual Sales by Company (2018-2023) 3.1.2 Global Ponatinib Sales Market Share by Company (2018-2023) 3.2 Global Ponatinib Annual Revenue by Company (2018-2023) 3.2.1 Global Ponatinib Revenue by Company (2018-2023) 3.2.2 Global Ponatinib Revenue Market Share by Company (2018-2023) 3.3 Global Ponatinib Sale Price by Company 3.4 Key Manufacturers Ponatinib Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Ponatinib Product Location Distribution 3.4.2 Players Ponatinib Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Ponatinib by Geographic Region 4.1 World Historic Ponatinib Market Size by Geographic Region (2018-2023) 4.1.1 Global Ponatinib Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Ponatinib Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Ponatinib Market Size by Country/Region (2018-2023) 4.2.1 Global Ponatinib Annual Sales by Country/Region (2018-2023) 4.2.2 Global Ponatinib Annual Revenue by Country/Region (2018-2023) 4.3 Americas Ponatinib Sales Growth 4.4 APAC Ponatinib Sales Growth 4.5 Europe Ponatinib Sales Growth 4.6 Middle East & Africa Ponatinib Sales Growth 5 Americas 5.1 Americas Ponatinib Sales by Country 5.1.1 Americas Ponatinib Sales by Country (2018-2023) 5.1.2 Americas Ponatinib Revenue by Country (2018-2023) 5.2 Americas Ponatinib Sales by Type 5.3 Americas Ponatinib Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Ponatinib Sales by Region 6.1.1 APAC Ponatinib Sales by Region (2018-2023) 6.1.2 APAC Ponatinib Revenue by Region (2018-2023) 6.2 APAC Ponatinib Sales by Type 6.3 APAC Ponatinib Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Ponatinib by Country 7.1.1 Europe Ponatinib Sales by Country (2018-2023) 7.1.2 Europe Ponatinib Revenue by Country (2018-2023) 7.2 Europe Ponatinib Sales by Type 7.3 Europe Ponatinib Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Ponatinib by Country 8.1.1 Middle East & Africa Ponatinib Sales by Country (2018-2023) 8.1.2 Middle East & Africa Ponatinib Revenue by Country (2018-2023) 8.2 Middle East & Africa Ponatinib Sales by Type 8.3 Middle East & Africa Ponatinib Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Ponatinib 10.3 Manufacturing Process Analysis of Ponatinib 10.4 Industry Chain Structure of Ponatinib 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Ponatinib Distributors 11.3 Ponatinib Customer 12 World Forecast Review for Ponatinib by Geographic Region 12.1 Global Ponatinib Market Size Forecast by Region 12.1.1 Global Ponatinib Forecast by Region (2024-2029) 12.1.2 Global Ponatinib Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Ponatinib Forecast by Type 12.7 Global Ponatinib Forecast by Application 13 Key Players Analysis 13.1 ARIAD Pharmaceuticals 13.1.1 ARIAD Pharmaceuticals Company Information 13.1.2 ARIAD Pharmaceuticals Ponatinib Product Portfolios and Specifications 13.1.3 ARIAD Pharmaceuticals Ponatinib Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 ARIAD Pharmaceuticals Main Business Overview 13.1.5 ARIAD Pharmaceuticals Latest Developments 14 Research Findings and Conclusion

List of Tables Table 1. Ponatinib Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Ponatinib Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of 45mg Table 4. Major Players of 15mg Table 5. Global Ponatinib Sales by Type (2018-2023) & (K Units) Table 6. Global Ponatinib Sales Market Share by Type (2018-2023) Table 7. Global Ponatinib Revenue by Type (2018-2023) & ($ million) Table 8. Global Ponatinib Revenue Market Share by Type (2018-2023) Table 9. Global Ponatinib Sale Price by Type (2018-2023) & (USD/Unit) Table 10. Global Ponatinib Sales by Application (2018-2023) & (K Units) Table 11. Global Ponatinib Sales Market Share by Application (2018-2023) Table 12. Global Ponatinib Revenue by Application (2018-2023) Table 13. Global Ponatinib Revenue Market Share by Application (2018-2023) Table 14. Global Ponatinib Sale Price by Application (2018-2023) & (USD/Unit) Table 15. Global Ponatinib Sales by Company (2018-2023) & (K Units) Table 16. Global Ponatinib Sales Market Share by Company (2018-2023) Table 17. Global Ponatinib Revenue by Company (2018-2023) ($ Millions) Table 18. Global Ponatinib Revenue Market Share by Company (2018-2023) Table 19. Global Ponatinib Sale Price by Company (2018-2023) & (USD/Unit) Table 20. Key Manufacturers Ponatinib Producing Area Distribution and Sales Area Table 21. Players Ponatinib Products Offered Table 22. Ponatinib Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Ponatinib Sales by Geographic Region (2018-2023) & (K Units) Table 26. Global Ponatinib Sales Market Share Geographic Region (2018-2023) Table 27. Global Ponatinib Revenue by Geographic Region (2018-2023) & ($ millions) Table 28. Global Ponatinib Revenue Market Share by Geographic Region (2018-2023) Table 29. Global Ponatinib Sales by Country/Region (2018-2023) & (K Units) Table 30. Global Ponatinib Sales Market Share by Country/Region (2018-2023) Table 31. Global Ponatinib Revenue by Country/Region (2018-2023) & ($ millions) Table 32. Global Ponatinib Revenue Market Share by Country/Region (2018-2023) Table 33. Americas Ponatinib Sales by Country (2018-2023) & (K Units) Table 34. Americas Ponatinib Sales Market Share by Country (2018-2023) Table 35. Americas Ponatinib Revenue by Country (2018-2023) & ($ Millions) Table 36. Americas Ponatinib Revenue Market Share by Country (2018-2023) Table 37. Americas Ponatinib Sales by Type (2018-2023) & (K Units) Table 38. Americas Ponatinib Sales by Application (2018-2023) & (K Units) Table 39. APAC Ponatinib Sales by Region (2018-2023) & (K Units) Table 40. APAC Ponatinib Sales Market Share by Region (2018-2023) Table 41. APAC Ponatinib Revenue by Region (2018-2023) & ($ Millions) Table 42. APAC Ponatinib Revenue Market Share by Region (2018-2023) Table 43. APAC Ponatinib Sales by Type (2018-2023) & (K Units) Table 44. APAC Ponatinib Sales by Application (2018-2023) & (K Units) Table 45. Europe Ponatinib Sales by Country (2018-2023) & (K Units) Table 46. Europe Ponatinib Sales Market Share by Country (2018-2023) Table 47. Europe Ponatinib Revenue by Country (2018-2023) & ($ Millions) Table 48. Europe Ponatinib Revenue Market Share by Country (2018-2023) Table 49. Europe Ponatinib Sales by Type (2018-2023) & (K Units) Table 50. Europe Ponatinib Sales by Application (2018-2023) & (K Units) Table 51. Middle East & Africa Ponatinib Sales by Country (2018-2023) & (K Units) Table 52. Middle East & Africa Ponatinib Sales Market Share by Country (2018-2023) Table 53. Middle East & Africa Ponatinib Revenue by Country (2018-2023) & ($ Millions) Table 54. Middle East & Africa Ponatinib Revenue Market Share by Country (2018-2023) Table 55. Middle East & Africa Ponatinib Sales by Type (2018-2023) & (K Units) Table 56. Middle East & Africa Ponatinib Sales by Application (2018-2023) & (K Units) Table 57. Key Market Drivers & Growth Opportunities of Ponatinib Table 58. Key Market Challenges & Risks of Ponatinib Table 59. Key Industry Trends of Ponatinib Table 60. Ponatinib Raw Material Table 61. Key Suppliers of Raw Materials Table 62. Ponatinib Distributors List Table 63. Ponatinib Customer List Table 64. Global Ponatinib Sales Forecast by Region (2024-2029) & (K Units) Table 65. Global Ponatinib Revenue Forecast by Region (2024-2029) & ($ millions) Table 66. Americas Ponatinib Sales Forecast by Country (2024-2029) & (K Units) Table 67. Americas Ponatinib Revenue Forecast by Country (2024-2029) & ($ millions) Table 68. APAC Ponatinib Sales Forecast by Region (2024-2029) & (K Units) Table 69. APAC Ponatinib Revenue Forecast by Region (2024-2029) & ($ millions) Table 70. Europe Ponatinib Sales Forecast by Country (2024-2029) & (K Units) Table 71. Europe Ponatinib Revenue Forecast by Country (2024-2029) & ($ millions) Table 72. Middle East & Africa Ponatinib Sales Forecast by Country (2024-2029) & (K Units) Table 73. Middle East & Africa Ponatinib Revenue Forecast by Country (2024-2029) & ($ millions) Table 74. Global Ponatinib Sales Forecast by Type (2024-2029) & (K Units) Table 75. Global Ponatinib Revenue Forecast by Type (2024-2029) & ($ Millions) Table 76. Global Ponatinib Sales Forecast by Application (2024-2029) & (K Units) Table 77. Global Ponatinib Revenue Forecast by Application (2024-2029) & ($ Millions) Table 78. ARIAD Pharmaceuticals Basic Information, Ponatinib Manufacturing Base, Sales Area and Its Competitors Table 79. ARIAD Pharmaceuticals Ponatinib Product Portfolios and Specifications Table 80. ARIAD Pharmaceuticals Ponatinib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 81. ARIAD Pharmaceuticals Main Business Table 82. ARIAD Pharmaceuticals Latest Developments List of Figures Figure 1. Picture of Ponatinib Figure 2. Ponatinib Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Ponatinib Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Ponatinib Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Ponatinib Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of 45mg Figure 10. Product Picture of 15mg Figure 11. Global Ponatinib Sales Market Share by Type in 2022 Figure 12. Global Ponatinib Revenue Market Share by Type (2018-2023) Figure 13. Ponatinib Consumed in CML Figure 14. Global Ponatinib Market: CML (2018-2023) & (K Units) Figure 15. Ponatinib Consumed in ALL Figure 16. Global Ponatinib Market: ALL (2018-2023) & (K Units) Figure 17. Global Ponatinib Sales Market Share by Application (2022) Figure 18. Global Ponatinib Revenue Market Share by Application in 2022 Figure 19. Ponatinib Sales Market by Company in 2022 (K Units) Figure 20. Global Ponatinib Sales Market Share by Company in 2022 Figure 21. Ponatinib Revenue Market by Company in 2022 ($ Million) Figure 22. Global Ponatinib Revenue Market Share by Company in 2022 Figure 23. Global Ponatinib Sales Market Share by Geographic Region (2018-2023) Figure 24. Global Ponatinib Revenue Market Share by Geographic Region in 2022 Figure 25. Americas Ponatinib Sales 2018-2023 (K Units) Figure 26. Americas Ponatinib Revenue 2018-2023 ($ Millions) Figure 27. APAC Ponatinib Sales 2018-2023 (K Units) Figure 28. APAC Ponatinib Revenue 2018-2023 ($ Millions) Figure 29. Europe Ponatinib Sales 2018-2023 (K Units) Figure 30. Europe Ponatinib Revenue 2018-2023 ($ Millions) Figure 31. Middle East & Africa Ponatinib Sales 2018-2023 (K Units) Figure 32. Middle East & Africa Ponatinib Revenue 2018-2023 ($ Millions) Figure 33. Americas Ponatinib Sales Market Share by Country in 2022 Figure 34. Americas Ponatinib Revenue Market Share by Country in 2022 Figure 35. Americas Ponatinib Sales Market Share by Type (2018-2023) Figure 36. Americas Ponatinib Sales Market Share by Application (2018-2023) Figure 37. United States Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 38. Canada Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 39. Mexico Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 40. Brazil Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 41. APAC Ponatinib Sales Market Share by Region in 2022 Figure 42. APAC Ponatinib Revenue Market Share by Regions in 2022 Figure 43. APAC Ponatinib Sales Market Share by Type (2018-2023) Figure 44. APAC Ponatinib Sales Market Share by Application (2018-2023) Figure 45. China Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 46. Japan Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 47. South Korea Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 48. Southeast Asia Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 49. India Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 50. Australia Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 51. China Taiwan Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 52. Europe Ponatinib Sales Market Share by Country in 2022 Figure 53. Europe Ponatinib Revenue Market Share by Country in 2022 Figure 54. Europe Ponatinib Sales Market Share by Type (2018-2023) Figure 55. Europe Ponatinib Sales Market Share by Application (2018-2023) Figure 56. Germany Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 57. France Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 58. UK Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 59. Italy Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 60. Russia Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 61. Middle East & Africa Ponatinib Sales Market Share by Country in 2022 Figure 62. Middle East & Africa Ponatinib Revenue Market Share by Country in 2022 Figure 63. Middle East & Africa Ponatinib Sales Market Share by Type (2018-2023) Figure 64. Middle East & Africa Ponatinib Sales Market Share by Application (2018-2023) Figure 65. Egypt Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 66. South Africa Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 67. Israel Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 68. Turkey Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 69. GCC Country Ponatinib Revenue Growth 2018-2023 ($ Millions) Figure 70. Manufacturing Cost Structure Analysis of Ponatinib in 2022 Figure 71. Manufacturing Process Analysis of Ponatinib Figure 72. Industry Chain Structure of Ponatinib Figure 73. Channels of Distribution Figure 74. Global Ponatinib Sales Market Forecast by Region (2024-2029) Figure 75. Global Ponatinib Revenue Market Share Forecast by Region (2024-2029) Figure 76. Global Ponatinib Sales Market Share Forecast by Type (2024-2029) Figure 77. Global Ponatinib Revenue Market Share Forecast by Type (2024-2029) Figure 78. Global Ponatinib Sales Market Share Forecast by Application (2024-2029) Figure 79. Global Ponatinib Revenue Market Share Forecast by Application (2024-2029)